This April marked the third annual Moving Beyond Cancer to Wellness (MBCTW) Conference in Anchorage, Alaska. Coalitions, advocacy and medical organizations sponsored the conference on living well during and after cancer for survivors, patients, caregivers, advocates and supporters. The GW Cancer Center's Allison Harvey, MPH, CHES, presented on this importance of survivorship care plans and how they can be used as a map to wellness. The MBTCW conference is in its 12th year in Seattle. View videos from past Seattle conferences.
Team-Based Oncology Care: The Pivotal Role of Patient Navigation
New Toolkits: National Cancer Survivors Day and Palliative Care
The GW Cancer Center is pleased to announce the release of two social media toolkits, one for
National Cancer Survivors Day on June 3, and one for
Palliative Care Awareness (new!) to be used throughout the year. Both toolkits contain evidence-informed messaging and best practices for utilizing social media.
Job Posting - ICF has a job opening for an oncology nurse in Rockville, Maryland.
Learn more and apply.
Engagement in Health Research Literature Explorer - This searchable database from PCORI contains literature on improving engagement in health research.
Viral Hepatitis and Liver Cancer Prevention Profiles - The GW Cancer Center recently published these fact sheets on liver cancer and viral hepatitis for each state as well as resources on reducing the burden of viral hepatitis. Learn more.
Archived Webinar: Developing State-Level Colorectal Cancer Coalitions - This webinar from the National Colorectal Cancer Roundtable discusses the process for establishing a state-level colorectal cancer roundtable. Learn more.
What We're Reading
Oncology Nurse Advisor - 2-Year Rituximab Maintenance Therapy Prolongs PFS in Elderly with CLL - Read the article or abstract.
New York Times -
Imaginative Caregiving for the Cancer Patient - Read the
Medical News Today -
This 'Metastasis-Blocking' Compound May Stop the Spread of Cancer - Read the
New York Times -
The Jabberwocky in a Cancer Lab - Read the
National Cancer Institute -
FDA Approves Nivolumab and Ipalimumab Combination for Advanced Kidney Cancer - Read the
Help us improve the Patient Navigation and Survivorship E-News! Take a few moments to fill out our survey and let us know what you think.